Cationic liposomes as vaccine adjuvants (Q37867105)

24 August 2017

1 reference

title

Cationic liposomes as vaccine adjuvants (English)

1 reference

24 August 2017

1 reference

1

1 reference

24 August 2017

4

Else Marie Agger

1 reference

24 August 2017

Karen Smith Korsholm

2

1 reference

PubMed ID

21506648

24 August 2017

Peter Andersen

series ordinal

3

1 reference

24 August 2017

1 April 2011

1 reference

Expert Review of Vaccines

24 August 2017

1 reference

24 August 2017

10

1 reference

24 August 2017

513-521

1 reference

24 August 2017

4

1 reference

Cationic liposomes as vaccine adjuvants

24 August 2017

1 reference

A new intranasal influenza vaccine based on a novel polycationic lipid--ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in mice.

21 January 2018

1 reference

DDA as an immunological adjuvant

21 January 2018

1 reference

Use of lipoplex-induced nuclear factor-kappaB activation to enhance transgene expression by lipoplex in mouse lung

21 January 2018

1 reference

Mucosal immunization against hepatitis A: antibody responses are enhanced by co-administration of synthetic oligodeoxynucleotides and a novel cationic lipid

21 January 2018

1 reference

DiC14-amidine cationic liposomes stimulate myeloid dendritic cells through Toll-like receptor 4.

21 January 2018

1 reference

Progress in cationic lipid-mediated gene transfection: a series of bio-inspired lipids as an example

21 January 2018

1 reference

Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis

21 January 2018

1 reference

Bacterial DNA is implicated in the inflammatory response to delivery of DNA/DOTAP to mouse lungs

21 January 2018

1 reference

Liposome-mediated DNA vaccination: the effect of vesicle composition

21 January 2018

1 reference

Liposome-mediated DNA immunisation via the subcutaneous route

21 January 2018

1 reference

Development of candidate combination vaccine for hepatitis E and hepatitis B: A liposome encapsulation approach

21 January 2018

1 reference

Liposome fusogenicity and entrapment efficiency of antigen determine the Th1/Th2 bias of antigen-specific immune response.

21 January 2018

1 reference

The effects of salt on the physicochemical properties and immunogenicity of protein based vaccine formulated in cationic liposome

21 January 2018

1 reference

Co-encapsulation of antigen and Toll-like receptor ligand in cationic liposomes affects the quality of the immune response in mice after intradermal vaccination

21 January 2018

1 reference

Immunostimulation mechanism of LPD nanoparticle as a vaccine carrier.

21 January 2018

1 reference

Mechanism of adjuvant activity of cationic liposome: phosphorylation of a MAP kinase, ERK and induction of chemokines

21 January 2018

1 reference

Reactive oxygen species play a central role in the activity of cationic liposome based cancer vaccine

21 January 2018

1 reference

Transcutaneous immunization by lipoplex-patch based DNA vaccines is effective vaccination against Japanese encephalitis virus infection.

21 January 2018

1 reference

Lipoplexes prepared from cationic liposomes and mammalian DNA induce CpG-independent, direct cytotoxic effects in cell cultures and in mice

21 January 2018

1 reference

Systemic administration of LPD prepared with CpG oligonucleotides inhibits the growth of established pulmonary metastases by stimulating innate and acquired antitumor immune responses

21 January 2018

1 reference

Intranasal administration of CpG DNA lipoplex prevents pulmonary metastasis in mice

21 January 2018

1 reference

Biosurfactant MEL-A enhances cellular association and gene transfection by cationic liposome

21 January 2018

1 reference

Cationic liposome (DC-Chol/DOPE=1:2) and a modified ethanol injection method to prepare liposomes, increased gene expression.

21 January 2018

1 reference

DC-Chol/DOPE cationic liposomes: a comparative study of the influence factors on plasmid pDNA and siRNA gene delivery

21 January 2018

1 reference

Design, characterization and preclinical efficacy of a cationic lipid adjuvant for influenza split vaccine

21 January 2018

1 reference

Phase I study of a candidate vaccine based on recombinant HIV-1 gp160 (MN/LAI) administered by the mucosal route to HIV-seronegative volunteers: the ANRS VAC14 study.

21 January 2018

1 reference

Female genital tract immunization: evaluation of candidate immunoadjuvants on epithelial cell secretion of CCL20 and dendritic/Langerhans cell maturation

21 January 2018

1 reference

Immunostimulatory lipid implants containing Quil-A and DC-cholesterol

21 January 2018

1 reference

In vivo activity of cationic immune stimulating complexes (PLUSCOMs).

21 January 2018

1 reference

Inhibition of human ovarian carcinoma cell proliferation by liposome-plasmid DNA complex

21 January 2018

1 reference

LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth

21 January 2018

1 reference

A Toll-like receptor recognizes bacterial DNA

21 January 2018

1 reference

Prophylaxis with cationic liposome-DNA complexes protects hamsters from phleboviral disease: importance of liposomal delivery and CpG motifs

21 January 2018

1 reference

Effective, broad spectrum control of virulent bacterial infections using cationic DNA liposome complexes combined with bacterial antigens

21 January 2018

1 reference

Efficacy of cationic lipid–DNA complexes (CLDC) on hepatitis B virus in transgenic mice

21 January 2018

1 reference

Potent adjuvant activity of cationic liposome-DNA complexes for genital herpes vaccines

21 January 2018

1 reference

A novel vaccine adjuvant for recombinant flu antigens

21 January 2018

1 reference

Rapid immunity to vaccination with woodchuck hepatitis virus surface antigen using cationic liposome-DNA complexes as adjuvant

21 January 2018

1 reference

Cationic lipid/DNA complexes (JVRS-100) combined with influenza vaccine (Fluzone) increases antibody response, cellular immunity, and antigenically drifted protection

21 January 2018

1 reference

Enhanced in vivo immunogenicity of SIV vaccine candidates with cationic liposome-DNA complexes in a rhesus macaque pilot study

21 January 2018

1 reference

Protection against pneumonic plague following oral immunization with a non-replicating vaccine

21 January 2018

1 reference

The adjuvant CLDC increases protection of a herpes simplex type 2 glycoprotein D vaccine in guinea pigs

21 January 2018

1 reference

Mucosal immunotherapy for protection from pneumonic infection with Francisella tularensis

21 January 2018

1 reference

Protection from pneumonic infection with burkholderia species by inhalational immunotherapy

21 January 2018

1 reference

Structural characterization of diC14-amidine, a pH-sensitive cationic lipid used for transfection

21 January 2018

1 reference

A novel cationic amphiphile for transfection of mammalian cells.

21 January 2018

1 reference

Vaccination with the recombinant allergen ProDer p 1 complexed with the cationic lipid DiC14-amidine prevents allergic responses to house dust mite

21 January 2018

1 reference

DiC14-amidine confers new anti-inflammatory properties to phospholipids

21 January 2018

1 reference

Combinations of two synthetic adjuvants: synergistic effects of a surfactant and a polyanion on the humoral immune response.

21 January 2018

1 reference

Liposomes based on dimethyldioctadecylammonium promote a depot effect and enhance immunogenicity of soluble antigen

21 January 2018

1 reference

The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes

21 January 2018

1 reference

ESAT-6 subunit vaccination against Mycobacterium tuberculosis

21 January 2018

1 reference

Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant

21 January 2018

1 reference

T-helper 1 and T-helper 2 adjuvants induce distinct differences in the magnitude, quality and kinetics of the early inflammatory response at the site of injection

21 January 2018

1 reference

Role of trehalose dimycolate in recruitment of cells and modulation of production of cytokines and NO in tuberculosis.

21 January 2018

1 reference

Immunological properties of trehalose dimycolate (cord factor) and other mycolic acid-containing glycolipids--a review

21 January 2018

1 reference

Trehalose 6,6'-dimycolate and lipid in the pathogenesis of caseating granulomas of tuberculosis in mice.

21 January 2018

1 reference

The role of trehalose dimycolate (cord factor) on morphology of virulent M. tuberculosis in vitro

21 January 2018

1 reference

Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRgamma-Syk-Card9-dependent innate immune activation

21 January 2018

1 reference

Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle

21 January 2018

1 reference

Mincle is a long sought receptor for mycobacterial cord factor

21 January 2018

1 reference

Cutting edge: Mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate

21 January 2018

1 reference

Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6'-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responses

21 January 2018

1 reference

Combination of the cationic surfactant dimethyl dioctadecyl ammonium bromide and synthetic mycobacterial cord factor as an efficient adjuvant for tuberculosis subunit vaccines

21 January 2018

1 reference

alpha,alpha'-trehalose 6,6'-dibehenate in non-phospholipid-based liposomes enables direct interaction with trehalose, offering stability during freeze-drying.

21 January 2018

1 reference

Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements

21 January 2018

1 reference

Syringe free vaccination with CAF01 Adjuvated Ag85B-ESAT-6 in Bioneedles provides strong and prolonged protection against tuberculosis

21 January 2018

1 reference

Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells

21 January 2018

1 reference

Liposome delivery of Chlamydia muridarum major outer membrane protein primes a Th1 response that protects against genital chlamydial infection in a mouse model

21 January 2018

1 reference

Protection against Chlamydia promoted by a subunit vaccine (CTH1) compared with a primary intranasal infection in a mouse genital challenge model

21 January 2018

1 reference

Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positive

21 January 2018

1 reference

A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cells

21 January 2018

1 reference

A simple mycobacterial monomycolated glycerol lipid has potent immunostimulatory activity

21 January 2018

1 reference

Novel generation mycobacterial adjuvant based on liposome-encapsulated monomycoloyl glycerol from Mycobacterium bovis bacillus Calmette-Guérin.

21 January 2018

1 reference

Adjuvant properties of a simplified C32 monomycolyl glycerol analogue

21 January 2018

1 reference

Incorporation of a synthetic mycobacterial monomycoloyl glycerol analogue stabilizes dimethyldioctadecylammonium liposomes and potentiates their adjuvant effect in vivo

21 January 2018

1 reference

gp63 in stable cationic liposomes confers sustained vaccine immunity to susceptible BALB/c mice infected with Leishmania donovani.

21 January 2018

1 reference

Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response

21 January 2018

1 reference

Comparison of the Depot Effect and Immunogenicity of Liposomes Based on Dimethyldioctadecylammonium (DDA), 3β-[N-(N′,N′-Dimethylaminoethane)carbomyl] Cholesterol (DC-Chol), and 1,2-Dioleoyl-3-trimethylammonium Propane (DOTAP): Prolonged Liposome

21 January 2018

1 reference

Comparison of vesicle based antigen delivery systems for delivery of hepatitis B surface antigen

21 January 2018

1 reference

Adjuvant modulation of the cytokine balance in Mycobacterium tuberculosis subunit vaccines; immunity, pathology and protection

21 January 2018

1 reference

Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6

21 January 2018

1 reference

Incorporation of the TLR4 Agonist Monophosphoryl Lipid A Into the Bilayer of DDA/TDB Liposomes: Physico-Chemical Characterization and Induction of CD8+ T-Cell Responses In Vivo

21 January 2018

1 reference

Immunostimulatory biodegradable implants containing the adjuvant Quil-A—Part I: Physicochemical characterisation

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.11.17

1 reference

24 August 2017

1 reference

PubMed ID

21506648